000 01377 a2200433 4500
005 20250512205423.0
264 0 _c19830527
008 198305s 0 0 eng d
022 _a0027-8874
040 _aNLM
_beng
_cNLM
100 1 _aKamaraju, L S
245 0 0 _aEpstein-Barr virus-related lymphocyte stimulation inhibitor: a possible prognostic tool for undifferentiated nasopharyngeal carcinoma.
_h[electronic resource]
260 _bJournal of the National Cancer Institute
_cApr 1983
300 _a643-7 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aAntibodies, Viral
_xanalysis
650 0 4 _aAntigens, Viral
650 0 4 _aDiagnosis, Differential
650 0 4 _aFemale
650 0 4 _aHead and Neck Neoplasms
_xdiagnosis
650 0 4 _aHerpesvirus 4, Human
_ximmunology
650 0 4 _aHumans
650 0 4 _aLymphocyte Activation
650 0 4 _aLymphocytes
_ximmunology
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aNasopharyngeal Neoplasms
_xdiagnosis
650 0 4 _aReference Values
700 1 _aLevine, P H
700 1 _aSundar, S K
700 1 _aAblashi, D V
700 1 _aFaggioni, A
700 1 _aArmstrong, G R
700 1 _aBertram, G
700 1 _aKrueger, G R
773 0 _tJournal of the National Cancer Institute
_gvol. 70
_gno. 4
_gp. 643-7
999 _c6300428
_d6300428